55216 Federal Register / Vol. 72, No. 188 / Friday, September 28, 2007 / Notices 

Exchange staff will facilitate 

communication among users and 

developers of innovations. However, the 

participation of the innovator is 

essential to the ability of the Health Care 

Innovations Exchange to foster and 

promote the diffusion of innovations 

through social learning, a central goal of 

this program. The level of participation 

can vary according to innovator interest 

and schedules. Innovators will be 

expected to respond to occasional 

inquiries and to join a Health Care 

Innovations Exchange community of 

practice related to the innovator’s 

particular innovation, so that ideas can 

be shared in an organized instructional 

fashion or setting. 

AHRQ’s Priorities 

• Specific populations. AHRQ is 

interested in identifying innovations 

that will help to reduce disparities in 

health care and health status. 

Populations of interest to AHRQ are 

low-income groups, minority groups, 

women, children, the elderly, and 

individuals with special health care 

needs. 

• Potential for high impact. The 

Health Care Innovations Exchange will 

give publication or dissemination 

priority to innovations that are likely to 

have a significant effect on the overall 

value of health care. Impact may be 

defined in different ways, e.g., the 

innovation may affect a broad 

population, address a critical health 

issue, or demonstrate large cost savings. 

• Innovator interest in participating. 

All else being equal, AHRQ will give 

priority to innovators who express a 

strong interest in becoming involved in 

other activities of the Health Care 

Innovations Exchange, such as 

participating in learning networks and 

providing commentaries. 

• AHRQ-funded innovations. The 

Health Care Innovations Exchange will 

aim to include effective innovations that 

are or were funded by the Agency. 

Dated: September 18, 2007. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 07–4771 Filed 9–27–07; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Availability of Draft Public Health 

Service (PHS) Clinical Practice 

Guideline Update on Treating Tobacco 

Use and Dependence 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice for pre-publication 

review and comment. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) 

announces the availability of a draft 

Public Health Service clinical practice 

guideline Update on Treating Tobacco 

Use and Dependence for pre-publication 

review. This PHS guideline update is 

being produced by a multidisciplinary 

private-sector panel of experts convened 

by the agencies of the Public Health 

Service. The expert panel will not 

respond to individual comments but 

will consider all comments in 

determining revisions to the guideline. 

DATES: Comments must be postmarked 

by October 26, 2007. 

Request for Draft PHS Guideline 

Update 

To receive a copy of the draft 

guideline update, requests must 

include: Requester’s name; Affiliation 

(business or organization); Address 

(including zip code); Telephone and Fax 

numbers. This is a draft document. 

Since changes are likely to be made to 

the draft guideline update during the 

review process this draft document 

should not be used as a clinical practice 

guideline until final publication. It is 

anticipated that the final guideline 

update will be made available to the 

public in the spring of 2008. 

You will be mailed a printed DRAFT 

copy of the draft guideline update and 

sent by e-mail: (1) An electronic form to 

submit any comments and (2) a short 

conflict of interest form to be completed 

by those submitting comments. 

ADDRESSES: Written requests, including 

your e-mail address, should be mailed 

to: David Fraser, Assistant Director for 

Research Administration, University of 

Wisconsin-Center for Tobacco Research 

and Intervention, 1930 Monroe Street, 

Suite 200, Madison, WI 53711–2027. 

Automated Review Process 

A computerized guideline review 

process enables comments to be entered 

on a special form designed for typed 

entry, documentation and consideration 

of all comments. The form will be sent 

by e-mail, with instructions, to those 

requesting the draft guideline update. 

To facilitate the review process, it is 

strongly recommended that reviewers 

use the computer form to record their 

comments. For technical assistance or 

questions regarding this input process, 

please follow the directions in the 

materials you receive. 

FOR FURTHER INFORMATION CONTACT: For 

information on the PHS Treating 

Tobacco Use and Dependence Clinical 

Practice Guideline Update, please 

contact: CAPT Ernestine Murray, Project 

Officer, Agency for Healthcare Research 

and Quality (AHRQ), Center for 

Outcomes and Evidence, 540 Gaither 

Road, Room 6337, Rockville, MD 20850, 

Telephone: 301–427–1630, E-mail 

Address: 

ernestine.murray@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: In July 

2006 a private-sector panel of experts 

was convened by the Agencies of the 

Public Health Service to update the PHS 

Treating Tobacco Use and Dependence 

Clinical Practice Guideline to improve 

the effectiveness of smoking cessation 

activities. A public meeting was also 

held in June 2007 for the panel to 

receive comments and information 

relevant to the update of the PHS 

guideline. The panel also reviewed and 

synthesized the literature on the topic 

and drafted a set of conclusions and 

recommendations based on the best 

available scientific data and expert 

judgments. A draft of these conclusions 

and recommendations is now 

undergoing peer review by a substantial 

number of individuals and groups who 

are knowledgeable about clinical 

treatment of tobacco dependence. 

With this notice, the panel and the 

PHS are also making the draft guideline 

available to other individuals who wish 

to provide written review comments. 

After review and evaluation of the 

comments received, the panel will make 

appropriate revisions to the current 

draft PHS guideline update and prepare 

the clinical practice guideline update on 

Treating Tobacco Use and Dependence. 

Potential reviewers should note that the 

PHS may disclose the names of the 

guideline reviewers at the same time the 

guideline is published. The PHS may 

also release review comments after the 

guideline is published. Generally, 

comments will not be attributed to 

specific reviewers. However, attribution 

may be necessary or useful to indicate 

the validity or reliability of particularly 

important comments. 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 72, No. 188 / Friday, September 28, 2007 / Notices 55217 

Dated: September 21, 2007. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 07–4770 Filed 9–27–07; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–07–0636] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–6974. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

State-based Evaluation of the Alert 

Notification Component of CDC’s 

Epidemic Information Exchange (Epi-X) 

Secure Public Health Communications 

Network (OMB No. 0920–0636)—

Extension—National Center for Health 

Marketing (NCHM), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

A central component of the CDC’s 

mission is to strengthen the nation’s 

public health infrastructure by 

coordinating public health surveillance 

at CDC and providing domestic and 

international support through scientific 

communications and terrorism 

preparedness and emergency response. 

The Epidemic Information Exchange 

(Epi-X) provides CDC and its state and 

local partners and collaborators with a 

secure public health communications 

network intended for routine and 

emergent information exchange in a 

secure environment. 

Great attention has been focused on 

improving secure public health 

communications networks for the 

dissemination of critical disease 

outbreak and/or bioterrorism-related 

events, which may have multijurisdictional involvement and cause 

disease and death within a short timeframe. 

The purpose of the information 

gathered during this notification 

proficiency testing exercise is to 

evaluate the extent to which new 

registrants and currently authorized 

users of the Epidemic Information 

Exchange (Epi-X) are able to utilize alert 

notification functionality to minimize or 

prevent unnecessary injury or diseaserelated morbidity and mortality through 

the use of secure communications and 

rapid notification systems. In this case, 

notification alerts would be sent to 

targeted public health professionals 

through a ‘barrage’ of office cell phone, 

home telephone, and pager calls to 

rapidly inform key health authorities 

from multidisciplinary backgrounds and 

multiple jurisdictions of evolving and 

critical public health information, and 

assist with the decision making process. 

Presently, the necessity of this 

evaluation process is timely because of 

ongoing terrorism threats and acts 

perpetrated worldwide. 

The survey information will be 

gathered through an online 

questionnaire format, and help evaluate 

user comprehension and facility solely 

with the targeted notification and rapid 

alerting functionalities of Epi-X. The 

questionnaire will consist of both 

closed- and open-ended items, and will 

be administered through Zoomerang, an 

online questionnaire program, or as a 

last resort, by telephone. Approximately 

2,000 Epi-X users from every state of the 

union will be asked to volunteer input 

(in a 5–10 question format) about their 

experiences using the alert notification 

functionalities of the Epi-X 

communications system. 

There will be no cost to respondents, 

whose participation will be strictly 

voluntary. The total estimated burden 

hours are 167. 

ESTIMATED ANNUALIZED BURDEN

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

per response 

(in hours) 

Public Health Professionals ................................................................................................... 1,000 1 10/60 

Dated: September 24, 2007. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–19198 Filed 9–27–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–07–07BR] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed project or to obtain a copy of 

data collection plans and instruments, 

call the CDC Reports Clearance Officer 

on 404–639–5960 or send comments to 

Maryam I. Daneshvar, CDC Acting 

Reports Clearance Officer, 1600 Clifton 

Road, MS D–74, Atlanta, GA 30333 or 

send an e-mail to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Written comments should be received 

within 60 days of this notice. 

Proposed Project 

National Survey of Residential Care 

Facilities (NSRCF) 2008–2010—New—

National Center for Health Statistics 

(NCHS), Centers for Disease Control and 

Prevention (CDC). 


jlentini on PROD1PC65 with NOTICES